Evidence map›Paper›PMID 38977352›Full record

ArticleNan fang yi ke da xue xue bao = Journal of Southern Medical University2024

[High expression of the stemness-associated molecule Nanog in esophageal squamous cell carcinoma tissues promotes tumor invasion and metastasis by activating the TGF-β signaling pathway].

C Sun, S Zheng, M Li, M Yang, M Qin, Y Xu, W Liang, J Hu, L Wang, F Li and 2 more

Abstract readEnglish Abstract
In one paragraph

Article in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

C SunDepartment of Pathology, Department of Pathology of First Affiliated Hospital, Shihezi University School of Medicine, Shihezi 832000, China.
S ZhengDepartment of Pathology, Department of Pathology of First Affiliated Hospital, Shihezi University School of Medicine, Shihezi 832000, China.
M LiDepartment of Pathology, Department of Pathology of First Affiliated Hospital, Shihezi University School of Medicine, Shihezi 832000, China.
M YangDepartment of Pathology, Department of Pathology of First Affiliated Hospital, Shihezi University School of Medicine, Shihezi 832000, China.
M QinDepartment of Pathology, Department of Pathology of First Affiliated Hospital, Shihezi University School of Medicine, Shihezi 832000, China.
Y XuDepartment of Pathology, Department of Pathology of First Affiliated Hospital, Shihezi University School of Medicine, Shihezi 832000, China.
W LiangDepartment of Pathology, Department of Pathology of First Affiliated Hospital, Shihezi University School of Medicine, Shihezi 832000, China.
J HuDepartment of Pathology, Department of Pathology of First Affiliated Hospital, Shihezi University School of Medicine, Shihezi 832000, China.
L WangDepartment of Pathology, Department of Pathology of First Affiliated Hospital, Shihezi University School of Medicine, Shihezi 832000, China.
F LiDepartment of Pathology, Department of Pathology of First Affiliated Hospital, Shihezi University School of Medicine, Shihezi 832000, China.
H ZhouANZAC Research Institute, University of Sydney, Sydney 2050, Australia.
L YangDepartment of Pathology, Department of Pathology of First Affiliated Hospital, Shihezi University School of Medicine, Shihezi 832000, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the expression of Nanog and its regulatory relationship with MMP-2/MMP-9 proteins in esophageal squamous cell carcinoma (ESCC).

methodsWe detected Nanog and MMP-2/MMP-9 protein expressions in 127 ESCC tissues and 82 adjacent normal tissues using immunohistochemistry and explored their correlations with the clinicopathological parameters and prognosis of the patients. GEO database was utilized to analyze the pathways enriched with the stemness-related molecules including Nanog, and TIMER online tool was used to analyze the correlations among TβR1, MMP-2, and MMP-9 in esophageal cancer.

resultsNanog and MMP-2/MMP-9 proteins were significantly upregulated in ESCC tissues and positively intercorrelated. Their expression levels were closely correlated with infiltration depth and lymph node metastasis of ESCC but not with age, gender, or tumor differentiation. The patients with high expressions of Nanog and MMP-2/MMP-9 had significantly shorter survival time. Bioinformatics analysis showed enrichment of stemness-associated molecules in the TGF-β signaling pathway, and the expressions of MMP-2/MMP-9 and TβR1 were positively correlated. In cultured ESCC cells, Nanog knockdown significantly decreased the expression of TβR1, p-Smad2/3, MMP-2, and MMP-9 and strongly inhibited cell migration.

conclusionThe high expressions of Nanog, MMP-2, and MMP-9, which are positively correlated, are closely related with invasion depth, lymph node metastasis, and prognosis of ESCC. Nanog regulates the expressions of MMP-2/MMP-9 proteins through the TGF-β signaling pathway, and its high expression promotes migration of ESCC cells.

Indexed as

Esophageal NeoplasmsEsophageal Squamous Cell CarcinomaLymphatic MetastasisMatrix Metalloproteinase 2Matrix Metalloproteinase 9Nanog Homeobox ProteinNeoplasm InvasivenessSignal TransductionTransforming Growth Factor betaFemaleHumansMalePrognosisMatrix Metalloproteinase 2Matrix Metalloproteinase 9MMP2 protein, humanMMP9 protein, humanNanog Homeobox ProteinNANOG protein, humanTransforming Growth Factor betaesophageal squamous cell carcinomainfiltration and metastasisMMP-2/MMP-9Nanogsurvival analysis

Identifiers

PMID38977352
PMCPMC11237290

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.